Drug
Bradykinin clinical trials
- studies test it
- 9
- open now
- 0
- in phase 3
- 0
- first study started
- 1999
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 1
- Phase 4
- 1
- No phase
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 9
Vanderbilt University (5) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Vanderbilt University Medical Center (1) · Emory University (1) · Heidelberg University (1)
Often tested with
Tested in the same studies.
Omega-N-Methylarginine (3) · Nitroprusside (2) · Acetylcholine (2) · Isosorbide (1) · Sildenafil (1) · Miconazole (1) · Valsartan (1) · Sacubitril valsartan sodium hydrate (1)
Studies
Open first, then newest update. How each study uses Bradykinin is read from its arms, and is right about nine times in ten.
Testing it · 9
- Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-critical Coronary Artery DiseaseTerminatedPhase 1Vanderbilt UniversityNCT00868855Written as Bradykinin
- Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1TerminatedPhase 4Vanderbilt University Medical CenterNCT03738878Written as Bradykinin
- Endothelial Hyperpolarization in HumansTerminatedPhase 2Emory UniversityNCT00166166Written as Bradykinin
- Characterization of Brachial Arterial t-PA Release, Endothelial Function, Obesity and InflammationTerminatedNot applicableVanderbilt UniversityNCT00780481Written as Bradykinin
- Intracoronary Bradykinin Mediated t-PA Release in Heart Transplant RecipientsWithdrawnNot applicableVanderbilt UniversityNCT00780377Written as Bradykinin
- Brachial Artery t-PA Release in Heart Transplant RecipientsWithdrawnNot applicableVanderbilt UniversityNCT00780637Written as Bradykinin
- Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3CompletedNot applicableVanderbilt UniversityNCT00685945Written as L-NMMA + bradykinin
- Effects of Miconazole on Blood FlowCompletedPhase 1National Heart, Lung, and Blood Institute (NHLBI)NCT00004575Written as Miconazole, L-NMMA, Bradykinin
- Vasoreactivity in Carriers of Genetic PolymorphismsStatus unknownPhase 1Heidelberg UniversityNCT00160888Written as sodium nitroprusside, bradykinin, acetylcholine
Given in every arm · 1 — Bradykinin is usual care beside what is tested
Codes
What other systems call Bradykinin · ClinicalTrials.gg INT007086
- MeSH (NLM) D001920BradykininConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) S8TIM42R2WBRADYKININConfirmed FDA, NLM
- NCI Thesaurus C316BradykininOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D001920 | Bradykinin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | S8TIM42R2W | BRADYKININ | Confirmed FDA, NLM |
| NCI Thesaurus | C316 | Bradykinin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.